Assessment of homologous and heterologous PCV2 vaccine efficacy in a PCV2d/PRRSV co-challenge model. Kroeger M, Fano E, Sponheim A, Schwartz KJ, et al. Vaccine 2025;60:127303.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kroeger M, Fano E, Sponheim A, Schwartz KJ, et al. Assessment of homologous and heterologous PCV2 vaccine efficacy in a PCV2d/PRRSV co-challenge model. Vaccine 2025;60:127303.
PMID: 40424703